Back to Journals » Cancer Management and Research » Volume 13
microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Received 10 June 2021
Accepted for publication 10 June 2021
Published 16 June 2021 Volume 2021:13 Pages 4765—4766
Lv L, Wang X, Ma T. Cancer Manag Res. 2019;11:2531–2543.
The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised that the flow cytometry data presented in Figure 2 and Figure 6 was previously published in other articles by other research groups. Specifically:
- Figure 2D panel miR-944 mimics appears to be duplicated with Figure 2D panel miR-411 mimics from Zhao et al, 2018 (https://doi.org/10.3892/or.2017.6135).
- Figure 6D panel Hep3B 1 appears to be duplicated with Figure 5F panel miR-543 mimics+pcDNA3.1-ADAM9 from Ji et al, 2017 (https://doi.org/10.3892/mmr.2017.7332).
- Figure 6D panel Hep3b 2 appears to be duplicated with Figure 5F panel miR-543 mimics from Ji et al, 2017 (https://doi.org/10.3892/mmr.2017.7332).
The authors were unable to provide a satisfactory explanation for the alleged data duplication and the decision was made to retract the article. The authors wish to apologise for this error.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.